Novel effector phenotype of Tim-3(+) regulatory T cells leads to enhanced suppressive function in head and neck cancer patients

Lignende værker

• Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
  af: Shayan, Gulidanna, et al.
  Udgivet: (2016)
• Increased PD-1(+) and TIM-3(+) TILs during cetuximab therapy inversely correlates with response in head and neck cancer patients
  af: Jie, Hyun-Bae, et al.
  Udgivet: (2017)
• Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients
  af: Li, Jing, et al.
  Udgivet: (2015)
• PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL
  af: Shayan, Gulidanna, et al.
  Udgivet: (2015)
• STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer
  af: Lu, Shanhong, et al.
  Udgivet: (2018)